Cargando…
Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19
BACKGROUND: Coronavirus disease 2019 (COVID-19) has spread worldwide and is also an important disease in Japan. Thus, the optimal treatment strategy for severe COVID-19 should be established urgently. The effects of combination treatment with baricitinib—a Janus kinase inhibitor, remdesivir, and dex...
Autores principales: | Izumo, Takehiro, Kuse, Naoyuki, Awano, Nobuyasu, Tone, Mari, Sakamoto, Keita, Takada, Kohei, Muto, Yutaka, Fujimoto, Kazushi, Saiki, Ayae, Ito, Yu, Matsumoto, Haruko, Inomata, Minoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Respiratory Society. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352677/ https://www.ncbi.nlm.nih.gov/pubmed/34413006 http://dx.doi.org/10.1016/j.resinv.2021.07.004 |
Ejemplares similares
-
Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan
por: Izumo, Takehiro, et al.
Publicado: (2021) -
Pulmonary amyloidosis diagnosed via transbronchial lung cryobiopsy without surgical lung biopsy: A case series
por: Fujimoto, Kazushi, et al.
Publicado: (2022) -
Predictive model for the development of critical coronavirus disease 2019 and its risk factors among patients in Japan
por: Muto, Yutaka, et al.
Publicado: (2021) -
Drug-induced hypersensitivity syndrome caused by minodronic acid hydrate
por: Muto, Yutaka, et al.
Publicado: (2021) -
An autopsy case of idiopathic pulmonary fibrosis with remarkable honeycomb cyst expansion
por: Ito, Yu, et al.
Publicado: (2022)